Dingshi Capital: Liu Yundi was appointed as an executive director, and Dingshi Capital (00804) announced that Ms. Liu Yundi had been appointed as an executive director, effective from December 12, 2024.Trump is reported to have talked about dividends and capital gains tax.Trump: For me, the stock market is everything and very important.
US National Security Adviser Sullivan: My goal is to reach a hostage exchange and ceasefire agreement (in Gaza) this month.Dong Ximiao, Principal Investigator of Zhaolian: Support small and medium-sized banks to better establish a long-term mechanism for capital replenishment. The Central Economic Work Conference proposed to effectively prevent and resolve risks in key areas and firmly hold the bottom line of systemic risks. The meeting also proposed that the risks of local small and medium-sized financial institutions should be properly handled. Dong Ximiao, chief researcher of Zhaolian, believes that more resolute and effective measures should be taken to promote the real estate market to stop falling and stabilize, speed up the reform of small and medium-sized financial institutions, and firmly hold the bottom line of no systemic risks. (SSE)The yield of German 10-year government bonds rose by 5 basis points to 2.18%, the highest level in two weeks.
Deutsche Bank: MARCUS CHROMIK was appointed as Chief Risk Officer.Lian Ping, Dean and Chief Economist of Guangkai Chief Industry Research Institute: It is expected that deficit ratio will be allocated 4%-4.5% next year, and its finance will be more active to meet the current economic needs. (Xinhua Finance)On average, the patients who won the bid from more than 6 enterprises for each drug can use the tenth batch of products won by the state in April next year. The reporter learned from the National Medical Insurance Bureau that the tenth batch of centralized drug purchase organized by the state has produced the results of the proposed bid, and 62 drugs have been successfully purchased, all of which have passed the patent period, and are produced by many enterprises and fully competitive. A total of 385 products from 234 enterprises were qualified to be selected, and on average, more than 6 enterprises of each variety planned to win the bid. In April next year, patients can use the bid-winning products after the price reduction of this centralized purchase.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide